Mali Wirotesangthong และผู้แต่งคนอื่นๆ. (2020) Adverse events of patients receiving rituximab, bevacizumab and omalizumab at King Chulalongkorn Memorial Hospital. <i>Isan Journal ofPharmaceutical Sciences</i>, <i>16</i>(2), 30-44.Mali Wirotesangthong และผู้แต่งคนอื่นๆ. "Adverse events of patients receiving rituximab, bevacizumab and omalizumab at King Chulalongkorn Memorial Hospital". Isan Journal ofPharmaceutical Sciences 16 (2020):30-44.Mali Wirotesangthong และผู้แต่งคนอื่นๆ. Adverse events of patients receiving rituximab, bevacizumab and omalizumab at King Chulalongkorn Memorial Hospital. Faculty of Pharmaceutical Sciences KKU MSU UBU:ม.ป.ท. 2020.